StonvexLoading…
StonvexStonvexStonvexCore line items from GENK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $212.54M | $208.38M | $181.01M | $163.73M |
Operating Income | $-19.99M | $476.00K | $8.09M | $12.35M |
Net Income | $-3.03M | $592.00K | $8.41M | $10.28M |
EPS (Diluted) | $-0.59 | $0.13 | $0.08 | Not available |
Total Assets | $259.86M | $240.41M | $183.87M | $138.88M |
Total Liabilities | $231.85M | $194.80M | $146.35M | $144.14M |
Cash & Equivalents | $2.82M | $23.68M | $32.63M | $11.20M |
Free Cash Flow OCF − CapEx | $-24.32M | $-6.00M | $5.01M | $15.29M |
Shares Outstanding | 5.16M | 4.67M | 4.23M | Not available |